FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078451741> ?p ?o ?g. }

• W2078451741 endingPage "1626" @default.
• W2078451741 startingPage "1620" @default.
• W2078451741 abstract "We aimed to characterize the spectrum of liver enzyme test (LET) abnormalities that occur while using methotrexate for inflammatory bowel disease (IBD).A retrospective review was undertaken of subjects using methotrexate for IBD at a single center. The clinical and epidemiological parameters, and hepatotoxicity risk factors, were recorded. Subjects were excluded if cumulative methotrexate doses could not be ascertained, if they had a diagnosis of rheumatoid arthritis or psoriasis, or if baseline and follow-up LETs were not available. Also noted were the cumulative methotrexate dose during the peak LET increase, severity of LET increase, and whether normalization occurred.Eighty-seven subjects were included (Crohn's disease, n=67; UC, n=17; indeterminate colitis n=3). The mean therapy duration was 81 weeks (3- to 364-week range), and the cumulative average dose was 1,813 mg (25-8,255-mg range). Thirty-seven (43%) subjects received a cumulative dose >1,500 mg. Sixty-seven (77%) had normal LETs, and in 51 (76%) LETs remained normal throughout methotrexate therapy. In the 16 (24%) who developed LET abnormalities, seven (44%) had underlying risk factor(s) for liver disease. Normalization (without dose reduction) occurred in 14 (88%) while continuing methotrexate. Of 20 subjects with abnormal LETs at baseline, nine (45%) subsequently normalized while continuing methotrexate, whereas nine (45%) worsened. Seventeen liver biopsies were performed in 11 and were classified as Roenigk's grade I in 15 (88%) subjects. Roenigk IIIb or IV was not seen.Methotrexate is commonly associated with LET abnormalities, but these frequently normalize while still on therapy, and in only 5% will drug discontinuation be necessary. Liver biopsies rarely have substantive abnormalities." @default.
• W2078451741 created "2016-06-24" @default.
• W2078451741 creator A5017585326 @default.
• W2078451741 creator A5027344949 @default.
• W2078451741 creator A5035654219 @default.
• W2078451741 creator A5071888944 @default.
• W2078451741 date "2010-07-01" @default.
• W2078451741 modified "2023-10-14" @default.
• W2078451741 title "Changes in Liver Biochemistry During Methotrexate Use for Inflammatory Bowel Disease" @default.
• W2078451741 cites W126845996 @default.
• W2078451741 cites W1974065253 @default.
• W2078451741 cites W1975751581 @default.
• W2078451741 cites W1979295423 @default.
• W2078451741 cites W2003106549 @default.
• W2078451741 cites W2005943107 @default.
• W2078451741 cites W2015908978 @default.
• W2078451741 cites W2023931001 @default.
• W2078451741 cites W2029782231 @default.
• W2078451741 cites W2037141936 @default.
• W2078451741 cites W2037707239 @default.
• W2078451741 cites W2037964557 @default.
• W2078451741 cites W2041260334 @default.
• W2078451741 cites W2050437475 @default.
• W2078451741 cites W2055280685 @default.
• W2078451741 cites W2055335630 @default.
• W2078451741 cites W2061421106 @default.
• W2078451741 cites W2068567051 @default.
• W2078451741 cites W2070639495 @default.
• W2078451741 cites W2086848741 @default.
• W2078451741 cites W2087652191 @default.
• W2078451741 cites W2089392787 @default.
• W2078451741 cites W2109505122 @default.
• W2078451741 cites W2109713854 @default.
• W2078451741 cites W2150210104 @default.
• W2078451741 cites W2321934992 @default.
• W2078451741 cites W2323383014 @default.
• W2078451741 cites W2326745462 @default.
• W2078451741 cites W3024153555 @default.
• W2078451741 cites W4240153397 @default.
• W2078451741 cites W4376849728 @default.
• W2078451741 cites W73738779 @default.
• W2078451741 doi "https://doi.org/10.1038/ajg.2010.21" @default.
• W2078451741 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20160715" @default.
• W2078451741 hasPublicationYear "2010" @default.
• W2078451741 type Work @default.
• W2078451741 sameAs 2078451741 @default.
• W2078451741 citedByCount "53" @default.
• W2078451741 countsByYear W20784517412012 @default.
• W2078451741 countsByYear W20784517412013 @default.
• W2078451741 countsByYear W20784517412014 @default.
• W2078451741 countsByYear W20784517412015 @default.
• W2078451741 countsByYear W20784517412016 @default.
• W2078451741 countsByYear W20784517412017 @default.
• W2078451741 countsByYear W20784517412018 @default.
• W2078451741 countsByYear W20784517412019 @default.
• W2078451741 countsByYear W20784517412020 @default.
• W2078451741 countsByYear W20784517412021 @default.
• W2078451741 countsByYear W20784517412022 @default.
• W2078451741 countsByYear W20784517412023 @default.
• W2078451741 crossrefType "journal-article" @default.
• W2078451741 hasAuthorship W2078451741A5017585326 @default.
• W2078451741 hasAuthorship W2078451741A5027344949 @default.
• W2078451741 hasAuthorship W2078451741A5035654219 @default.
• W2078451741 hasAuthorship W2078451741A5071888944 @default.
• W2078451741 hasConcept C126322002 @default.
• W2078451741 hasConcept C151032500 @default.
• W2078451741 hasConcept C203014093 @default.
• W2078451741 hasConcept C2777575956 @default.
• W2078451741 hasConcept C2778260677 @default.
• W2078451741 hasConcept C2779134260 @default.
• W2078451741 hasConcept C2780479503 @default.
• W2078451741 hasConcept C2780564577 @default.
• W2078451741 hasConcept C2781059491 @default.
• W2078451741 hasConcept C71924100 @default.
• W2078451741 hasConcept C90924648 @default.
• W2078451741 hasConceptScore W2078451741C126322002 @default.
• W2078451741 hasConceptScore W2078451741C151032500 @default.
• W2078451741 hasConceptScore W2078451741C203014093 @default.
• W2078451741 hasConceptScore W2078451741C2777575956 @default.
• W2078451741 hasConceptScore W2078451741C2778260677 @default.
• W2078451741 hasConceptScore W2078451741C2779134260 @default.
• W2078451741 hasConceptScore W2078451741C2780479503 @default.
• W2078451741 hasConceptScore W2078451741C2780564577 @default.
• W2078451741 hasConceptScore W2078451741C2781059491 @default.
• W2078451741 hasConceptScore W2078451741C71924100 @default.
• W2078451741 hasConceptScore W2078451741C90924648 @default.
• W2078451741 hasIssue "7" @default.
• W2078451741 hasLocation W20784517411 @default.
• W2078451741 hasLocation W20784517412 @default.
• W2078451741 hasOpenAccess W2078451741 @default.
• W2078451741 hasPrimaryLocation W20784517411 @default.
• W2078451741 hasRelatedWork W2070285775 @default.
• W2078451741 hasRelatedWork W2076390064 @default.
• W2078451741 hasRelatedWork W2086360535 @default.
• W2078451741 hasRelatedWork W2125075787 @default.
• W2078451741 hasRelatedWork W2258300052 @default.
• W2078451741 hasRelatedWork W2408939568 @default.
• W2078451741 hasRelatedWork W2418837291 @default.

• next